.

Company Profile

LIQUID BIOPSIES
A Revolution In Cancer Diagnostics

OncoCyte is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer.

We are developing non-invasive molecular diagnostics for earlier and more accurate detection which will:

  • Improve patient outcomes
  • Significantly reduce healthcare costs
  • Increase the life expectancy of cancer patients